Rabies Exposure Alerts Demand Prompt Clinical Action

What the national alert means

The CDC Health Alert Network notice, issued September 11, 2026, describes an increase in reported human rabies exposures across the United States. The signal concerns exposures, not necessarily confirmed human infections. It nevertheless matters because every additional bite, scratch or contact event creates a narrow clinical decision point: determine whether rabies virus transmission was plausible and, if so, start post-exposure prophylaxis before symptoms develop.

Rabies is uncommon in people in the United States, but the consequence of a missed exposure is exceptionally high. Once clinical illness begins, rabies is almost invariably fatal. Post-exposure prophylaxis, or PEP, is highly effective when appropriate wound care, rabies immune globulin and vaccine are delivered correctly and before symptom onset.

A rise in reports does not by itself establish why exposures increased. Changes in wildlife activity, animal infections, human-animal contact, reporting behavior or awareness could contribute. The alert is surveillance-based rather than a controlled epidemiologic study, so it cannot estimate a causal effect or compare outcomes between exposed groups. Its practical value is early warning and clinical readiness.

A rapid exposure-assessment workflow

Assessment begins with the contact, not simply the presence of an animal. Rabies transmission generally requires a bite or scratch that breaks the skin, or direct contact of saliva or neural tissue with a mucous membrane or fresh open wound. Touching an animal, contact with intact skin, and exposure to blood, urine or feces alone are not ordinarily considered rabies exposures.

Clean every bite or contaminated wound promptly and thoroughly with soap and water. A virucidal agent such as povidone-iodine may be used when available. Wound care should not wait for animal testing or a final PEP decision. Clinicians should also address bacterial infection risk, tetanus prevention and structural injury independently of the rabies assessment.

Document the animal species; whether it was wild, owned or stray; its behavior and apparent health; whether the encounter was provoked; the location and date; and whether the animal can be captured safely for observation or testing. Local epidemiology matters. Bats are the leading source of domestically acquired human rabies in the United States, while raccoons, skunks and foxes are important terrestrial reservoirs in different regions.

Bat encounters require particular care because small bites or scratches may be difficult to identify. Direct contact warrants assessment unless the person can be reasonably certain that no bite, scratch or mucous-membrane exposure occurred. Merely finding a bat in a building does not automatically establish exposure; the circumstances and the person’s ability to reliably exclude contact should be reviewed with public health authorities.

Healthy dogs, cats and ferrets that expose a person can often undergo a 10-day observation period coordinated with animal control or public health officials. An animal that remains healthy through that period was not infectious at the time of the event. Observation rules should not be extrapolated to wildlife or other domestic species, for which management generally depends on species, circumstances and laboratory testing.

Decide with public health, but do not lose time

Clinicians should contact the state or local health department when an exposure is uncertain, the animal is wild or unavailable, testing is being arranged, or local epidemiology could alter the decision. Consultation can prevent both missed prophylaxis and unnecessary treatment. Emergency departments and urgent care centers should maintain current contact pathways for nights, weekends and holidays.

The urgency depends on risk. For a high-risk exposure involving a bat or a potentially rabid terrestrial mammal that is unavailable for testing, PEP generally should not be deferred while prolonged efforts are made to locate the animal. For a low-risk event involving a healthy dog, cat or ferret available for formal observation, public health authorities may support waiting for the observation outcome. If testing is planned, the responsible agency should coordinate specimen submission to an approved laboratory.

PEP for a person who has not previously received rabies vaccination consists of immediate wound care, human rabies immune globulin and a vaccine series. Immune globulin provides passive antibody at the exposure site while active immunity develops. As much of the calculated dose as anatomically feasible should be infiltrated into and around the wound; any remainder is administered away from the vaccine site. It must not be mixed with vaccine or injected into the same anatomical site as the first vaccine dose.

For infants and young children, the anterolateral thigh is an acceptable vaccine site. Pregnancy is not a contraindication to PEP. When a patient presents days or weeks after an exposure, prophylaxis can still be indicated if the exposure was credible and symptoms have not begun; the interval alone should not be used to dismiss risk.

If immune globulin was omitted when vaccine began, CDC guidance allows it to be administered through day 7 after the first vaccine dose. After that point, vaccine-induced antibody is expected to be developing and immune globulin is generally not given. Major schedule deviations, uncertain prior vaccination or immune suppression warrant public health consultation rather than improvisation.

Where errors occur

Common failures are incomplete exposure histories, assuming a small wound is inconsequential, injecting immune globulin only intramuscularly rather than into the wound, administering vaccine in the gluteal area, or giving immune globulin to a previously vaccinated person. Another risk is allowing uncertainty about animal testing to become an open-ended delay.

A practical safeguard is a standardized order set paired with a checklist: exposure date and route, species, animal availability, public health contact, wound irrigation, prior vaccination, immune status, immune globulin infiltration and vaccine follow-up dates. Discharge planning should identify where each remaining dose will be administered. A schedule that exists only in the medical record is vulnerable to missed doses.

Limits of the evidence

The Health Alert Network notice is a surveillance communication, not a randomized trial or population-based causal analysis. Reported exposures depend on recognition, health care access and reporting practices, and the alert cannot determine whether the increase reflects more hazardous encounters, greater awareness or both. It also does not make national averages a substitute for state and local rabies epidemiology.

PEP recommendations are based on virology, observational evidence, immunogenicity data and extensive public health experience because withholding prophylaxis after a credible exposure would be unethical. Clinicians should therefore interpret the alert as a prompt to strengthen reliable processes, not as evidence that every animal encounter requires vaccination.

Questions clinicians ask

Can PEP wait while an animal is tested or observed?

Sometimes. A healthy dog, cat or ferret may be observed for 10 days under public health direction, while an available wild animal may undergo expedited testing. When the animal is high risk, unavailable or testing will be delayed, clinicians should consult public health promptly and avoid an open-ended postponement of PEP.

What if the patient presents well after the exposure?

A delayed presentation does not automatically eliminate the indication for prophylaxis. For a credible exposure in a person without rabies symptoms, CDC guidance supports PEP even when time has elapsed. The exposure circumstances, animal species, test results and local epidemiology should drive the decision.

Should immune globulin be given after vaccine has already started?

For a previously unvaccinated person, omitted human rabies immune globulin can generally be given through day 7 after the first vaccine dose. It is not recommended after that point and should never be given to someone who previously completed an accepted rabies vaccination regimen.

What changes for an immunocompromised patient?

CDC recommends a five-dose vaccine regimen for immunocompromised people who were not previously vaccinated, together with wound care and immune globulin. Serologic testing should confirm an adequate response after completion. Because the degree of immune suppression and prior vaccination history may be complex, these cases merit early public health consultation.

References

1. Nationwide Increase in Reported Human Rabies Exposures — Centers for Disease Control and Prevention, 2026
2. Rabies Post-exposure Prophylaxis — Centers for Disease Control and Prevention, n.d.
3. Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies — Centers for Disease Control and Prevention, 2010
4. Human Rabies Prevention—United States, 2008: Recommendations of the Advisory Committee on Immunization Practices — Centers for Disease Control and Prevention, 2008